These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37245119)

  • 21. Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012-2017: implications for policy and regulatory change.
    Bonny-Noach H; Berkovitz R; Shapira B
    Isr J Health Policy Res; 2020 May; 9(1):14. PubMed ID: 32362275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk profile of male college athletes who use performance-enhancing substances.
    Buckman JF; Yusko DA; White HR; Pandina RJ
    J Stud Alcohol Drugs; 2009 Nov; 70(6):919-23. PubMed ID: 19895768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Success, Failure, and Unfinished Business of Education, Prevention, Policy, and Intervention Programs on Substance Misuse in Brazilian Sport.
    Santos AM
    Subst Use Misuse; 2015; 50(8-9):1139-43. PubMed ID: 26361918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sports psychiatrist and performance-enhancing drugs.
    Creado S; Reardon C
    Int Rev Psychiatry; 2016 Dec; 28(6):564-571. PubMed ID: 27310472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug use in sports: a veritable arena for pharmacists.
    Ambrose PJ
    J Am Pharm Assoc (2003); 2004; 44(4):501-14; quiz 514-6. PubMed ID: 15372871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk and enabling environments in sport: Systematic doping as harm reduction.
    Henning A; McLean K; Andreasson J; Dimeo P
    Int J Drug Policy; 2021 May; 91():102897. PubMed ID: 32768155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review.
    Brennan R; Wells JSG; Van Hout MC
    Health Soc Care Community; 2017 Sep; 25(5):1459-1531. PubMed ID: 26806443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Educational opportunities and anti-doping roles and responsibilities for pharmacists.
    Ambrose PJ
    Yakugaku Zasshi; 2011; 131(12):1761-4. PubMed ID: 22129874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sport motivation and doping in adolescent athletes.
    Mudrak J; Slepicka P; Slepickova I
    PLoS One; 2018; 13(10):e0205222. PubMed ID: 30286200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology.
    Adami PE; Koutlianos N; Baggish A; Bermon S; Cavarretta E; Deligiannis A; Furlanello F; Kouidi E; Marques-Vidal P; Niebauer J; Pelliccia A; Sharma S; Solberg EE; Stuart M; Papadakis M
    Eur J Prev Cardiol; 2022 Mar; 29(3):559-575. PubMed ID: 35081615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
    Jalleh G; Donovan RJ; Jobling I
    J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Education Interventions to Improve Knowledge, Beliefs, Intentions and Practices with Respect to Dietary Supplements and Doping Substances: A Narrative Review.
    Daher J; El Khoury D; Dwyer JJM
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appearance and Performance Enhancing Drugs and Substances: The Role of the School Nurse.
    Siegmund LA
    NASN Sch Nurse; 2022 Sep; 37(5):263-269. PubMed ID: 35466806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and incidence of injuries among female cricket players: a systematic review and meta-analysis.
    Jacobs J; Olivier B; Dawood M; Perera NKP
    JBI Evid Synth; 2022 Jul; 20(7):1741-1790. PubMed ID: 34954723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Can furosemide mask the use of performance-enhancing drugs?].
    Brinkman DJ; Tichelaar J; Van Agtmael MA
    Ned Tijdschr Geneeskd; 2021 May; 165():. PubMed ID: 34346634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Progressive Use of Performance Enhancing Substances by High-Performance Athletes.
    Smith ACT; Stavros C
    Subst Use Misuse; 2020; 55(6):914-927. PubMed ID: 31918609
    [No Abstract]   [Full Text] [Related]  

  • 39. Opinion paper: scientific, philosophical and legal consideration of doping in sports.
    Negro M; Marzullo N; Caso F; Calanni L; D'Antona G
    Eur J Appl Physiol; 2018 Apr; 118(4):729-736. PubMed ID: 29427238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.